| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule minus-end binding | 1.32e-04 | 15 | 23 | 2 | GO:0051011 | |
| GeneOntologyBiologicalProcess | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway | 1.19e-05 | 5 | 23 | 2 | GO:0090611 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process | 5.60e-05 | 640 | 23 | 6 | GO:0006511 | |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | 6.16e-05 | 651 | 23 | 6 | GO:0019941 | |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | 6.43e-05 | 656 | 23 | 6 | GO:0043632 | |
| GeneOntologyBiologicalProcess | multivesicular body-lysosome fusion | 9.21e-05 | 13 | 23 | 2 | GO:0061763 | |
| GeneOntologyBiologicalProcess | vesicle fusion with vacuole | 9.21e-05 | 13 | 23 | 2 | GO:0051469 | |
| GeneOntologyBiologicalProcess | vacuole fusion | 1.07e-04 | 14 | 23 | 2 | GO:0097576 | |
| GeneOntologyBiologicalProcess | viral budding from plasma membrane | 1.07e-04 | 14 | 23 | 2 | GO:0046761 | |
| GeneOntologyBiologicalProcess | non-lytic viral release | 1.24e-04 | 15 | 23 | 2 | GO:0046753 | |
| GeneOntologyBiologicalProcess | lysosomal membrane organization | 1.80e-04 | 18 | 23 | 2 | GO:0097212 | |
| GeneOntologyBiologicalProcess | type B pancreatic cell apoptotic process | 1.80e-04 | 18 | 23 | 2 | GO:0097050 | |
| GeneOntologyBiologicalProcess | endosome to lysosome transport via multivesicular body sorting pathway | 2.01e-04 | 19 | 23 | 2 | GO:0032510 | |
| GeneOntologyBiologicalProcess | midbody abscission | 2.01e-04 | 19 | 23 | 2 | GO:0061952 | |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | 2.08e-04 | 812 | 23 | 6 | GO:0051603 | |
| GeneOntologyBiologicalProcess | post-translational protein targeting to endoplasmic reticulum membrane | 2.47e-04 | 21 | 23 | 2 | GO:0006620 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 2.85e-04 | 293 | 23 | 4 | GO:0032886 | |
| GeneOntologyBiologicalProcess | late endosome to lysosome transport | 2.97e-04 | 23 | 23 | 2 | GO:1902774 | |
| GeneOntologyBiologicalProcess | viral budding via host ESCRT complex | 2.97e-04 | 23 | 23 | 2 | GO:0039702 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle assembly | 3.23e-04 | 24 | 23 | 2 | GO:1901673 | |
| GeneOntologyBiologicalProcess | nuclear membrane reassembly | 3.80e-04 | 26 | 23 | 2 | GO:0031468 | |
| GeneOntologyBiologicalProcess | viral budding | 3.80e-04 | 26 | 23 | 2 | GO:0046755 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport via multivesicular body sorting pathway | 4.10e-04 | 27 | 23 | 2 | GO:0032511 | |
| GeneOntologyBiologicalProcess | viral release from host cell | 5.08e-04 | 30 | 23 | 2 | GO:0019076 | |
| GeneOntologyBiologicalProcess | exit from host cell | 5.08e-04 | 30 | 23 | 2 | GO:0035891 | |
| GeneOntologyBiologicalProcess | multivesicular body assembly | 6.15e-04 | 33 | 23 | 2 | GO:0036258 | |
| GeneOntologyBiologicalProcess | mitotic cytokinetic process | 6.15e-04 | 33 | 23 | 2 | GO:1902410 | |
| GeneOntologyBiologicalProcess | multivesicular body organization | 6.53e-04 | 34 | 23 | 2 | GO:0036257 | |
| GeneOntologyBiologicalProcess | regulation of spindle assembly | 6.53e-04 | 34 | 23 | 2 | GO:0090169 | |
| GeneOntologyBiologicalProcess | plasma membrane repair | 6.53e-04 | 34 | 23 | 2 | GO:0001778 | |
| GeneOntologyBiologicalProcess | virion assembly | 6.92e-04 | 35 | 23 | 2 | GO:0019068 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 7.74e-04 | 37 | 23 | 2 | GO:0043162 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport | 8.60e-04 | 39 | 23 | 2 | GO:0045324 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 9.54e-04 | 176 | 23 | 3 | GO:0070507 | |
| GeneOntologyBiologicalProcess | endosome transport via multivesicular body sorting pathway | 1.04e-03 | 43 | 23 | 2 | GO:0032509 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle organization | 1.09e-03 | 44 | 23 | 2 | GO:0060236 | |
| GeneOntologyBiologicalProcess | protein catabolic process | 1.12e-03 | 1115 | 23 | 6 | GO:0030163 | |
| GeneOntologyBiologicalProcess | cytokinetic process | 1.30e-03 | 48 | 23 | 2 | GO:0032506 | |
| GeneOntologyBiologicalProcess | regulation of spindle organization | 1.30e-03 | 48 | 23 | 2 | GO:0090224 | |
| GeneOntologyBiologicalProcess | nuclear membrane organization | 1.30e-03 | 48 | 23 | 2 | GO:0071763 | |
| GeneOntologyBiologicalProcess | membrane fission | 1.30e-03 | 48 | 23 | 2 | GO:0090148 | |
| GeneOntologyBiologicalProcess | multivesicular body sorting pathway | 1.47e-03 | 51 | 23 | 2 | GO:0071985 | |
| GeneOntologyBiologicalProcess | protein targeting to ER | 1.52e-03 | 52 | 23 | 2 | GO:0045047 | |
| GeneOntologyBiologicalProcess | regulation of centrosome duplication | 1.52e-03 | 52 | 23 | 2 | GO:0010824 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to endoplasmic reticulum | 1.77e-03 | 56 | 23 | 2 | GO:0072599 | |
| GeneOntologyBiologicalProcess | nuclear envelope organization | 2.23e-03 | 63 | 23 | 2 | GO:0006998 | |
| GeneOntologyBiologicalProcess | regulation of centrosome cycle | 2.23e-03 | 63 | 23 | 2 | GO:0046605 | |
| GeneOntologyBiologicalProcess | membrane assembly | 2.30e-03 | 64 | 23 | 2 | GO:0071709 | |
| GeneOntologyBiologicalProcess | mitotic metaphase chromosome alignment | 2.37e-03 | 65 | 23 | 2 | GO:0007080 | |
| GeneOntologyBiologicalProcess | autophagosome maturation | 2.67e-03 | 69 | 23 | 2 | GO:0097352 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 2.98e-03 | 73 | 23 | 2 | GO:0044091 | |
| GeneOntologyBiologicalProcess | centrosome duplication | 3.65e-03 | 81 | 23 | 2 | GO:0051298 | |
| GeneOntologyBiologicalProcess | endosome to lysosome transport | 3.92e-03 | 84 | 23 | 2 | GO:0008333 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 3.99e-03 | 291 | 23 | 3 | GO:0032984 | |
| GeneOntologyBiologicalProcess | neuron development | 4.46e-03 | 1463 | 23 | 6 | GO:0048666 | |
| GeneOntologyBiologicalProcess | protein localization to endoplasmic reticulum | 4.49e-03 | 90 | 23 | 2 | GO:0070972 | |
| GeneOntologyBiologicalProcess | vesicle budding from membrane | 4.59e-03 | 91 | 23 | 2 | GO:0006900 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 4.68e-03 | 92 | 23 | 2 | GO:0090307 | |
| GeneOntologyCellularComponent | amphisome membrane | 8.97e-05 | 13 | 23 | 2 | GO:1904930 | |
| GeneOntologyCellularComponent | ESCRT III complex | 1.05e-04 | 14 | 23 | 2 | GO:0000815 | |
| GeneOntologyCellularComponent | amphisome | 1.21e-04 | 15 | 23 | 2 | GO:0044753 | |
| GeneOntologyCellularComponent | ciliary rootlet | 1.38e-04 | 16 | 23 | 2 | GO:0035253 | |
| GeneOntologyCellularComponent | microtubule | 2.43e-04 | 533 | 23 | 5 | GO:0005874 | |
| GeneOntologyCellularComponent | kinetochore microtubule | 2.64e-04 | 22 | 23 | 2 | GO:0005828 | |
| GeneOntologyCellularComponent | multivesicular body membrane | 4.94e-04 | 30 | 23 | 2 | GO:0032585 | |
| GeneOntologyCellularComponent | ESCRT complex | 5.63e-04 | 32 | 23 | 2 | GO:0036452 | |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 8.37e-04 | 39 | 23 | 2 | GO:0031463 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.40e-03 | 1179 | 23 | 6 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.45e-03 | 1187 | 23 | 6 | GO:0099081 | |
| GeneOntologyCellularComponent | autophagosome membrane | 1.78e-03 | 57 | 23 | 2 | GO:0000421 | |
| GeneOntologyCellularComponent | proteasome complex | 2.45e-03 | 67 | 23 | 2 | GO:0000502 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 2.56e-03 | 899 | 23 | 5 | GO:0099513 | |
| GeneOntologyCellularComponent | spindle microtubule | 4.00e-03 | 86 | 23 | 2 | GO:0005876 | |
| GeneOntologyCellularComponent | multivesicular body | 4.19e-03 | 88 | 23 | 2 | GO:0005771 | |
| GeneOntologyCellularComponent | nuclear pore | 5.47e-03 | 101 | 23 | 2 | GO:0005643 | |
| GeneOntologyCellularComponent | endopeptidase complex | 5.58e-03 | 102 | 23 | 2 | GO:1905369 | |
| GeneOntologyCellularComponent | autophagosome | 7.52e-03 | 119 | 23 | 2 | GO:0005776 | |
| Domain | Snf7_fam | 8.68e-05 | 12 | 22 | 2 | IPR005024 | |
| Domain | Snf7 | 8.68e-05 | 12 | 22 | 2 | PF03357 | |
| Domain | MATH/TRAF_dom | 8.68e-05 | 12 | 22 | 2 | IPR002083 | |
| Domain | MATH | 8.68e-05 | 12 | 22 | 2 | PS50144 | |
| Domain | MATH | 8.68e-05 | 12 | 22 | 2 | SM00061 | |
| Domain | MATH | 8.68e-05 | 12 | 22 | 2 | PF00917 | |
| Domain | - | 1.20e-04 | 14 | 22 | 2 | 2.60.210.10 | |
| Domain | TRAF-like | 3.60e-04 | 24 | 22 | 2 | IPR008974 | |
| Domain | - | 3.13e-03 | 71 | 22 | 2 | 1.10.418.10 | |
| Domain | CH | 3.31e-03 | 73 | 22 | 2 | PS50021 | |
| Domain | CH-domain | 3.49e-03 | 75 | 22 | 2 | IPR001715 | |
| Domain | BTB | 1.03e-02 | 131 | 22 | 2 | PF00651 | |
| Domain | BTB | 1.51e-02 | 160 | 22 | 2 | PS50097 | |
| Domain | BTB | 1.88e-02 | 180 | 22 | 2 | SM00225 | |
| Domain | BTB/POZ_dom | 1.98e-02 | 185 | 22 | 2 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 2.06e-02 | 189 | 22 | 2 | IPR011333 | |
| Pathway | REACTOME_HEDGEHOG_ON_STATE | 4.57e-06 | 81 | 20 | 4 | MM15225 | |
| Pathway | REACTOME_HEDGEHOG_ON_STATE | 5.81e-06 | 86 | 20 | 4 | M27497 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 3.67e-05 | 137 | 20 | 4 | MM15182 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 5.23e-05 | 150 | 20 | 4 | M27440 | |
| Pathway | REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX | 1.72e-04 | 14 | 20 | 2 | M39008 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 1.96e-04 | 211 | 20 | 4 | M27436 | |
| Pathway | REACTOME_HIV_INFECTION | 2.77e-04 | 231 | 20 | 4 | M12469 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.91e-04 | 234 | 20 | 4 | MM14898 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 3.00e-04 | 236 | 20 | 4 | M27185 | |
| Pathway | REACTOME_PYROPTOSIS | 5.18e-04 | 24 | 20 | 2 | MM15212 | |
| Pathway | REACTOME_PYROPTOSIS | 6.57e-04 | 27 | 20 | 2 | M41804 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 6.57e-04 | 27 | 20 | 2 | MM15674 | |
| Pathway | REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION | 7.07e-04 | 28 | 20 | 2 | M26982 | |
| Pathway | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | 8.68e-04 | 31 | 20 | 2 | M1009 | |
| Pathway | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | 8.68e-04 | 31 | 20 | 2 | MM15637 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 9.25e-04 | 32 | 20 | 2 | M29848 | |
| Pathway | REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY | 1.04e-03 | 34 | 20 | 2 | M27942 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.17e-03 | 36 | 20 | 2 | M47758 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.17e-03 | 36 | 20 | 2 | M47713 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.17e-03 | 36 | 20 | 2 | M47714 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.17e-03 | 36 | 20 | 2 | M47702 | |
| Pathway | REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS | 1.24e-03 | 37 | 20 | 2 | M45028 | |
| Pathway | KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.37e-03 | 39 | 20 | 2 | M47701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.44e-03 | 40 | 20 | 2 | M47749 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.44e-03 | 40 | 20 | 2 | M47748 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.52e-03 | 41 | 20 | 2 | M47747 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 1.67e-03 | 43 | 20 | 2 | M39706 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 1.83e-03 | 45 | 20 | 2 | M39864 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 1.90e-03 | 177 | 20 | 3 | M27476 | |
| Pathway | REACTOME_M_PHASE | 1.91e-03 | 387 | 20 | 4 | MM15364 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | 2.07e-03 | 48 | 20 | 2 | MM14528 | |
| Pathway | REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY | 2.25e-03 | 50 | 20 | 2 | MM17068 | |
| Pathway | REACTOME_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A | 2.25e-03 | 50 | 20 | 2 | MM15385 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | 2.25e-03 | 50 | 20 | 2 | M510 | |
| Pathway | REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY | 2.43e-03 | 52 | 20 | 2 | MM15536 | |
| Pathway | REACTOME_M_PHASE | 2.51e-03 | 417 | 20 | 4 | M27662 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2 | 2.52e-03 | 53 | 20 | 2 | MM16640 | |
| Pathway | REACTOME_DEGRADATION_OF_AXIN | 2.52e-03 | 53 | 20 | 2 | MM15152 | |
| Pathway | REACTOME_STABILIZATION_OF_P53 | 2.62e-03 | 54 | 20 | 2 | MM15384 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING | 2.62e-03 | 54 | 20 | 2 | M27931 | |
| Pathway | REACTOME_DEGRADATION_OF_AXIN | 2.71e-03 | 55 | 20 | 2 | M27398 | |
| Pathway | REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA | 2.71e-03 | 55 | 20 | 2 | MM15137 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 2.71e-03 | 55 | 20 | 2 | MM15153 | |
| Pathway | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | 2.71e-03 | 55 | 20 | 2 | M17095 | |
| Pathway | REACTOME_SOMITOGENESIS | 2.71e-03 | 55 | 20 | 2 | M48032 | |
| Pathway | REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA | 2.71e-03 | 55 | 20 | 2 | M998 | |
| Pathway | REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY | 2.71e-03 | 55 | 20 | 2 | M27809 | |
| Pathway | REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING | 2.81e-03 | 56 | 20 | 2 | MM15203 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 2.81e-03 | 56 | 20 | 2 | MM15901 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 2.91e-03 | 57 | 20 | 2 | M27399 | |
| Pathway | REACTOME_GLI3_IS_PROCESSED_TO_GLI3R_BY_THE_PROTEASOME | 2.91e-03 | 57 | 20 | 2 | MM15205 | |
| Pathway | REACTOME_STABILIZATION_OF_P53 | 2.91e-03 | 57 | 20 | 2 | M27670 | |
| Pathway | REACTOME_METABOLISM_OF_POLYAMINES | 2.91e-03 | 57 | 20 | 2 | MM14955 | |
| Pathway | REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21 | 3.01e-03 | 58 | 20 | 2 | MM14715 | |
| Pathway | REACTOME_REGULATED_NECROSIS | 3.12e-03 | 59 | 20 | 2 | M41803 | |
| Pathway | REACTOME_REGULATED_NECROSIS | 3.12e-03 | 59 | 20 | 2 | MM15169 | |
| Pathway | REACTOME_METABOLISM_OF_POLYAMINES | 3.12e-03 | 59 | 20 | 2 | M747 | |
| Pathway | REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21 | 3.22e-03 | 60 | 20 | 2 | M1081 | |
| Pathway | REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME | 3.22e-03 | 60 | 20 | 2 | M27470 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 3.22e-03 | 60 | 20 | 2 | MM15150 | |
| Pathway | REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS | 3.33e-03 | 61 | 20 | 2 | M27563 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 3.44e-03 | 62 | 20 | 2 | M39639 | |
| Pathway | REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING | 3.44e-03 | 62 | 20 | 2 | M27465 | |
| Pathway | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | 3.44e-03 | 62 | 20 | 2 | MM14514 | |
| Pathway | REACTOME_HEDGEHOG_LIGAND_BIOGENESIS | 3.44e-03 | 62 | 20 | 2 | MM15181 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 | 3.44e-03 | 62 | 20 | 2 | MM15521 | |
| Pathway | REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS | 3.66e-03 | 64 | 20 | 2 | MM15386 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 3.66e-03 | 64 | 20 | 2 | M27396 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | 3.77e-03 | 65 | 20 | 2 | MM15530 | |
| Pathway | REACTOME_HEDGEHOG_LIGAND_BIOGENESIS | 3.77e-03 | 65 | 20 | 2 | M27439 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 3.88e-03 | 66 | 20 | 2 | MM15261 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 4.12e-03 | 68 | 20 | 2 | MM14921 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 4.12e-03 | 68 | 20 | 2 | M27539 | |
| Pathway | REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS | 4.12e-03 | 68 | 20 | 2 | M27672 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 4.24e-03 | 69 | 20 | 2 | MM15540 | |
| Pathway | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | 4.24e-03 | 69 | 20 | 2 | MM15366 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA | 4.24e-03 | 69 | 20 | 2 | MM14522 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 4.24e-03 | 69 | 20 | 2 | M46439 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 4.24e-03 | 69 | 20 | 2 | M27815 | |
| Pathway | REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY | 4.36e-03 | 70 | 20 | 2 | MM15389 | |
| Pathway | REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6 | 4.48e-03 | 71 | 20 | 2 | MM15370 | |
| Pathway | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | 4.48e-03 | 71 | 20 | 2 | M4138 | |
| Pathway | REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY | 4.61e-03 | 72 | 20 | 2 | M27802 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 4.73e-03 | 73 | 20 | 2 | MM15491 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 4.73e-03 | 73 | 20 | 2 | MM15285 | |
| Pathway | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | 4.86e-03 | 74 | 20 | 2 | M1030 | |
| Pathway | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | 4.86e-03 | 74 | 20 | 2 | MM14678 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA | 4.99e-03 | 75 | 20 | 2 | M641 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 5.12e-03 | 76 | 20 | 2 | M27215 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 5.12e-03 | 76 | 20 | 2 | MM14526 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 5.12e-03 | 76 | 20 | 2 | MM15520 | |
| Pathway | REACTOME_ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | 5.25e-03 | 77 | 20 | 2 | MM14692 | |
| Pathway | REACTOME_KEAP1_NFE2L2_PATHWAY | 5.25e-03 | 77 | 20 | 2 | MM15698 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 5.25e-03 | 77 | 20 | 2 | MM14513 | |
| Pathway | REACTOME_ABC_TRANSPORTER_DISORDERS | 5.38e-03 | 78 | 20 | 2 | M27473 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 5.52e-03 | 79 | 20 | 2 | M27743 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 5.52e-03 | 79 | 20 | 2 | MM14754 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.66e-03 | 261 | 20 | 3 | M42565 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 5.79e-03 | 81 | 20 | 2 | M595 | |
| Pathway | REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX | 5.79e-03 | 81 | 20 | 2 | MM15360 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 16740475 | ||
| Pubmed | Roadkill attenuates Hedgehog responses through degradation of Cubitus interruptus. | 4.56e-07 | 2 | 24 | 2 | 16651542 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 20399258 | ||
| Pubmed | ALIX and ESCRT-I/II function as parallel ESCRT-III recruiters in cytokinetic abscission. | 1.37e-06 | 3 | 24 | 2 | 26929449 | |
| Pubmed | ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. | 1.37e-06 | 3 | 24 | 2 | 17683935 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 21494275 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 18511562 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 14678797 | ||
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 22724069 | ||
| Pubmed | Dynamics of ESCRT protein recruitment during retroviral assembly. | 4.56e-06 | 5 | 24 | 2 | 21394083 | |
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 12860994 | ||
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 14583093 | ||
| Pubmed | Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase. | 4.56e-06 | 5 | 24 | 2 | 22632832 | |
| Pubmed | Temporal and spatial organization of ESCRT protein recruitment during HIV-1 budding. | 4.56e-06 | 5 | 24 | 2 | 25099357 | |
| Pubmed | Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome. | 1.27e-05 | 8 | 24 | 2 | 20507940 | |
| Pubmed | 1.27e-05 | 8 | 24 | 2 | 22547407 | ||
| Pubmed | 1.27e-05 | 8 | 24 | 2 | 25005938 | ||
| Pubmed | 1.58e-05 | 223 | 24 | 4 | 30572598 | ||
| Pubmed | Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release. | 1.64e-05 | 9 | 24 | 2 | 18641129 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 1.90e-05 | 847 | 24 | 6 | 35235311 | |
| Pubmed | 2.50e-05 | 11 | 24 | 2 | 17984323 | ||
| Pubmed | 2.50e-05 | 11 | 24 | 2 | 17711858 | ||
| Pubmed | 2.50e-05 | 11 | 24 | 2 | 36107470 | ||
| Pubmed | Structure of cellular ESCRT-III spirals and their relationship to HIV budding. | 3.00e-05 | 12 | 24 | 2 | 24878737 | |
| Pubmed | Spop regulates Gli3 activity and Shh signaling in dorsoventral patterning of the mouse spinal cord. | 3.00e-05 | 12 | 24 | 2 | 28412462 | |
| Pubmed | 3.54e-05 | 13 | 24 | 2 | 16554368 | ||
| Pubmed | 3.54e-05 | 13 | 24 | 2 | 24482116 | ||
| Pubmed | 3.86e-05 | 1442 | 24 | 7 | 35575683 | ||
| Pubmed | 4.13e-05 | 14 | 24 | 2 | 26040713 | ||
| Pubmed | Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing. | 4.77e-05 | 15 | 24 | 2 | 26040712 | |
| Pubmed | Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a conserved VSL region in Vta1. | 4.77e-05 | 15 | 24 | 2 | 16505166 | |
| Pubmed | AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. | 4.77e-05 | 15 | 24 | 2 | 14505569 | |
| Pubmed | Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance. | 4.77e-05 | 15 | 24 | 2 | 20616062 | |
| Pubmed | 4.77e-05 | 15 | 24 | 2 | 19234443 | ||
| Pubmed | 6.94e-05 | 18 | 24 | 2 | 14505570 | ||
| Pubmed | 6.94e-05 | 18 | 24 | 2 | 14519844 | ||
| Pubmed | Spop promotes skeletal development and homeostasis by positively regulating Ihh signaling. | 7.75e-05 | 19 | 24 | 2 | 27930311 | |
| Pubmed | 1.06e-04 | 1153 | 24 | 6 | 29845934 | ||
| Pubmed | 1.47e-04 | 396 | 24 | 4 | 26687479 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.69e-04 | 411 | 24 | 4 | 35182466 | |
| Pubmed | Membrane budding and scission by the ESCRT machinery: it's all in the neck. | 1.83e-04 | 29 | 24 | 2 | 20588296 | |
| Pubmed | 1.87e-04 | 162 | 24 | 3 | 15174051 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 2.22e-04 | 1321 | 24 | 6 | 27173435 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 2.53e-04 | 853 | 24 | 5 | 28718761 | |
| Pubmed | 2.99e-04 | 37 | 24 | 2 | 12719574 | ||
| Pubmed | Evidence for a newly discovered cellular anti-HIV-1 phenotype. | 2.99e-04 | 37 | 24 | 2 | 9846577 | |
| Pubmed | 2.99e-04 | 37 | 24 | 2 | 8811196 | ||
| Pubmed | 2.99e-04 | 37 | 24 | 2 | 9811770 | ||
| Pubmed | Hypermutation of HIV-1 DNA in the absence of the Vif protein. | 2.99e-04 | 37 | 24 | 2 | 12750511 | |
| Pubmed | Death by deamination: a novel host restriction system for HIV-1. | 2.99e-04 | 37 | 24 | 2 | 12914693 | |
| Pubmed | 2.99e-04 | 37 | 24 | 2 | 12830140 | ||
| Pubmed | 2.99e-04 | 37 | 24 | 2 | 12840737 | ||
| Pubmed | The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. | 3.16e-04 | 38 | 24 | 2 | 12808465 | |
| Pubmed | 3.16e-04 | 38 | 24 | 2 | 12808466 | ||
| Pubmed | 3.16e-04 | 38 | 24 | 2 | 12920286 | ||
| Pubmed | 3.16e-04 | 38 | 24 | 2 | 10893419 | ||
| Pubmed | 3.16e-04 | 38 | 24 | 2 | 14557625 | ||
| Pubmed | 3.16e-04 | 38 | 24 | 2 | 14527406 | ||
| Pubmed | DNA deamination mediates innate immunity to retroviral infection. | 3.16e-04 | 38 | 24 | 2 | 12809610 | |
| Pubmed | 3.16e-04 | 38 | 24 | 2 | 12970355 | ||
| Pubmed | The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. | 3.16e-04 | 38 | 24 | 2 | 14614829 | |
| Pubmed | HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. | 3.33e-04 | 39 | 24 | 2 | 14528301 | |
| Pubmed | 3.46e-04 | 496 | 24 | 4 | 31343991 | ||
| Pubmed | 3.50e-04 | 40 | 24 | 2 | 12419264 | ||
| Pubmed | The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. | 3.50e-04 | 40 | 24 | 2 | 14528300 | |
| Pubmed | Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. | 3.50e-04 | 40 | 24 | 2 | 12167863 | |
| Pubmed | HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation. | 3.68e-04 | 41 | 24 | 2 | 9079628 | |
| Pubmed | 3.68e-04 | 41 | 24 | 2 | 14550573 | ||
| Pubmed | Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. | 4.05e-04 | 43 | 24 | 2 | 14564014 | |
| Pubmed | Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. | 4.24e-04 | 44 | 24 | 2 | 12859895 | |
| Pubmed | 4.44e-04 | 45 | 24 | 2 | 1286667 | ||
| Pubmed | Genetic variations strongly influence phenotypic outcome in the mouse retina. | 4.64e-04 | 46 | 24 | 2 | 21779340 | |
| Pubmed | 4.64e-04 | 46 | 24 | 2 | 28821611 | ||
| Pubmed | 4.64e-04 | 46 | 24 | 2 | 19928837 | ||
| Pubmed | 5.48e-04 | 234 | 24 | 3 | 36243803 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 5.64e-04 | 1016 | 24 | 5 | 19056867 | |
| Pubmed | Molecular Details Underlying Dynamic Structures and Regulation of the Human 26S Proteasome. | 5.70e-04 | 51 | 24 | 2 | 28292943 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 5.84e-04 | 1024 | 24 | 5 | 24711643 | |
| Pubmed | 6.63e-04 | 55 | 24 | 2 | 12791267 | ||
| Pubmed | 6.63e-04 | 55 | 24 | 2 | 18570454 | ||
| Interaction | MSLNL interactions | 2.03e-05 | 6 | 24 | 2 | int:MSLNL | |
| Interaction | RPS4X interactions | 3.21e-05 | 540 | 24 | 6 | int:RPS4X | |
| Interaction | PPP1R12A interactions | 3.34e-05 | 322 | 24 | 5 | int:PPP1R12A | |
| Interaction | TFPT interactions | 3.59e-05 | 160 | 24 | 4 | int:TFPT | |
| Interaction | RBM14 interactions | 3.67e-05 | 553 | 24 | 6 | int:RBM14 | |
| Interaction | DDX5 interactions | 4.26e-05 | 568 | 24 | 6 | int:DDX5 | |
| Interaction | SPC25 interactions | 5.89e-05 | 64 | 24 | 3 | int:SPC25 | |
| Interaction | PMFBP1 interactions | 6.08e-05 | 10 | 24 | 2 | int:PMFBP1 | |
| Interaction | CSRP1 interactions | 6.18e-05 | 65 | 24 | 3 | int:CSRP1 | |
| Interaction | METTL25 interactions | 7.43e-05 | 11 | 24 | 2 | int:METTL25 | |
| Interaction | DEK interactions | 1.01e-04 | 209 | 24 | 4 | int:DEK | |
| Interaction | LIMD2 interactions | 1.61e-04 | 16 | 24 | 2 | int:LIMD2 | |
| Interaction | MSRB3 interactions | 1.63e-04 | 90 | 24 | 3 | int:MSRB3 | |
| Interaction | ELSPBP1 interactions | 1.74e-04 | 92 | 24 | 3 | int:ELSPBP1 | |
| Interaction | MACROH2A1 interactions | 1.76e-04 | 458 | 24 | 5 | int:MACROH2A1 | |
| Interaction | YWHAQ interactions | 2.38e-04 | 1118 | 24 | 7 | int:YWHAQ | |
| Interaction | ACTN3 interactions | 2.87e-04 | 109 | 24 | 3 | int:ACTN3 | |
| Interaction | CNTNAP4 interactions | 3.09e-04 | 22 | 24 | 2 | int:CNTNAP4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 4.76e-04 | 294 | 24 | 3 | chr1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q21 | 4.52e-03 | 192 | 24 | 2 | chr8q21 | |
| GeneFamily | Charged multivesicular body proteins|ESCRT-III | 1.54e-05 | 7 | 16 | 2 | 1118 | |
| GeneFamily | Charged multivesicular body proteins|ESCRT-III associated factors | 4.02e-05 | 11 | 16 | 2 | 482 | |
| GeneFamily | Proteasome | 6.49e-04 | 43 | 16 | 2 | 690 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 6.11e-03 | 134 | 16 | 2 | 861 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-06 | 190 | 23 | 4 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-06 | 190 | 23 | 4 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-06 | 190 | 23 | 4 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.15e-05 | 120 | 23 | 3 | 2b7596946f9268c4202348adf3069decd8313bb0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 7.28e-05 | 159 | 23 | 3 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 7.28e-05 | 159 | 23 | 3 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-05 | 169 | 23 | 3 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-05 | 171 | 23 | 3 | 5447b78148f7bccb727e2fc108589b2af02a5d31 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-05 | 171 | 23 | 3 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-05 | 172 | 23 | 3 | a7eee0a30d2fe20c865a07b9004c6a821a72c0c4 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-05 | 172 | 23 | 3 | 0a9fe2cd28203970295a1288078c66eadac1c9ed | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 9.19e-05 | 172 | 23 | 3 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.67e-05 | 175 | 23 | 3 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.67e-05 | 175 | 23 | 3 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 176 | 23 | 3 | b81e5d23b31cefc8d374ef403e21acc390c14a80 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 176 | 23 | 3 | 057d2759fdc67176c25802b57a78064d8cc93205 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.00e-04 | 177 | 23 | 3 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.00e-04 | 177 | 23 | 3 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 178 | 23 | 3 | 0f5cf34609df791c8baebfdc6590f6eb4dbe0509 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 178 | 23 | 3 | d9eba884e18a0c89bdc70c194bfe4d62cca164fa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 178 | 23 | 3 | b03aa1de9d20895ebad55f6fcd6fe7a49335db5a | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 181 | 23 | 3 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 181 | 23 | 3 | cc77ac0e223e012767222e45c5dcadc246d1aa7c | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 181 | 23 | 3 | b0fff0defba9aea6fba36e378b05a59986e2573a | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 181 | 23 | 3 | ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 182 | 23 | 3 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 182 | 23 | 3 | 0cde2775bdaaa2172499925bd59b0ac2d545eb27 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 182 | 23 | 3 | 2cc434e46985c66fc36de05344a67aa96d90abc9 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 182 | 23 | 3 | 3e7457b2a70b45735fb75d6617b7f34cef28758e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 185 | 23 | 3 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 185 | 23 | 3 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 185 | 23 | 3 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 187 | 23 | 3 | b7689e7f6511920cd2beff27389555fddf685f61 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-04 | 190 | 23 | 3 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-04 | 190 | 23 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-04 | 190 | 23 | 3 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-04 | 190 | 23 | 3 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 191 | 23 | 3 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 191 | 23 | 3 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.37e-04 | 197 | 23 | 3 | a72047b7428c0d4aaf016c1ac23dc30919260fd8 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-04 | 199 | 23 | 3 | 1587d24b19f5bb64a3b6cc1df87c7c472cf41672 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-04 | 199 | 23 | 3 | a9c2041e54899cb8ccc026758647f3ae3ca457dd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 199 | 23 | 3 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|erythropoietic / Lineage and Cell class | 1.44e-04 | 200 | 23 | 3 | 27056f28328df2a51d5634a7927b7084241e3ca2 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.44e-04 | 200 | 23 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-04 | 60 | 23 | 2 | 71eba0fbef11cfc2b1c525d5f051530750e4fce9 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-04 | 60 | 23 | 2 | 28415d543aaccc74d19e1bb92b7e6fa94f97f8f2 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_Hsd17b2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.33e-04 | 78 | 23 | 2 | e5dbb0986cbee58fb1e5e464a3b003c4136246e7 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.32e-04 | 88 | 23 | 2 | fcc15c5c30517c63a835b28627c5f779d9bcd17e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.32e-04 | 88 | 23 | 2 | 7838c65160cf81c02b923fc34f566c0610c8d81b | |
| ToppCell | mLN-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 1.20e-03 | 100 | 23 | 2 | c560326f6ae5338aecdf11ef8adf04bc8769745c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-03 | 108 | 23 | 2 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-03 | 108 | 23 | 2 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-03 | 118 | 23 | 2 | aefad0b35aff980b6a2a98057735442e8a65ab04 | |
| ToppCell | LPS-IL1RA-Unknown|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-03 | 118 | 23 | 2 | 6cb4063b83f867b782080ce5b1199b51bb277f2a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.01e-03 | 130 | 23 | 2 | c63f402d6ab71c2fcef12174b3139e55a727266c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.08e-03 | 132 | 23 | 2 | 66ec5a06eece27c0aafb548f51db9fee595e71bc | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.08e-03 | 132 | 23 | 2 | dbc0a332fd8f63ebdcf9716e45d7f46f26509349 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-03 | 132 | 23 | 2 | a1fda8c5287168c4f159203ed27cadfb4ce1b131 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-03 | 144 | 23 | 2 | f769be4da268980ea7c06d7097ec39d06777e675 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-03 | 144 | 23 | 2 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.53e-03 | 146 | 23 | 2 | 159dd157a74f3c27dc1a1dcbbf0ed8f9462cac9e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 2.53e-03 | 146 | 23 | 2 | 1cb2e157222631e8915d89b255a843d16d7d99cc | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.60e-03 | 148 | 23 | 2 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-03 | 149 | 23 | 2 | f4bee5fdaaa4a1917e403de90e5a62353006df24 | |
| ToppCell | Healthy_donor-B_cell|World / disease group, cell group and cell class (v2) | 2.67e-03 | 150 | 23 | 2 | a2dfed562de7f58f902b547acec5a13853c80c4c | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-03 | 150 | 23 | 2 | 96b160f163030fbf48aedc37d6ae224e11492c52 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-03 | 152 | 23 | 2 | 82a493ffb2f1704cd6f68a82d970fe12f537d20e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-03 | 153 | 23 | 2 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2) | 2.77e-03 | 153 | 23 | 2 | 2b4c69f6db17927d6506a645ac058133e60b0103 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.77e-03 | 153 | 23 | 2 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| ToppCell | facs-Skin-nan-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-03 | 155 | 23 | 2 | fa2776d258e0420b2895de1008e292ad7725dac0 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.85e-03 | 155 | 23 | 2 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.85e-03 | 155 | 23 | 2 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.85e-03 | 155 | 23 | 2 | 96c48d835725eac1bc7926f4cddecb67c29b7d7c | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.85e-03 | 155 | 23 | 2 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 2.88e-03 | 156 | 23 | 2 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-03 | 156 | 23 | 2 | a4b0e89255ea5d60198cb2b3e739981f9c9cf5c5 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-03 | 157 | 23 | 2 | 6a0aa66964eecbbc232abf1d2e6c8422e4ce69d0 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-03 | 157 | 23 | 2 | fc127e7720649e746f3d3f5c2e9e63784767106a | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-03 | 157 | 23 | 2 | 7ceae5fe00c91d4feb8c314d3a31f027c03fa56f | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-03 | 157 | 23 | 2 | 66a191cef4aa00811bb04462310d012610006f85 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-03 | 158 | 23 | 2 | 9a6d9b541446a6aa9f8ed040b330dbb5c6447076 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-03 | 158 | 23 | 2 | 2438713d2a7e32c647ab3384237ed614f4ec8fec | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.99e-03 | 159 | 23 | 2 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.99e-03 | 159 | 23 | 2 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-03 | 161 | 23 | 2 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-03 | 161 | 23 | 2 | f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.06e-03 | 161 | 23 | 2 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-03 | 161 | 23 | 2 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-03 | 161 | 23 | 2 | 8937f6b92cb2a93ea8c4780d9200a518c3112e53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.06e-03 | 161 | 23 | 2 | 580153e131247e6ec12a1a920f050a0a763e7e87 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-03 | 161 | 23 | 2 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-03 | 161 | 23 | 2 | 110cc7122e3c9f105a11d811d77c8a8852b9de6c | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-03 | 161 | 23 | 2 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-03 | 161 | 23 | 2 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | cellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-ILC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.10e-03 | 162 | 23 | 2 | 553f91eaba72bcffb733ede45418bbee39c653ab | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-03 | 163 | 23 | 2 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.14e-03 | 163 | 23 | 2 | 5cbab3d03bb1af9391ecad635d6eea1dd42c1337 | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.14e-03 | 163 | 23 | 2 | 322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6 | |
| Disease | loneliness measurement | 1.21e-04 | 124 | 23 | 3 | EFO_0007865 | |
| Disease | fatty acid measurement | 3.33e-04 | 436 | 23 | 4 | EFO_0005110 | |
| Disease | PR interval | 5.38e-04 | 495 | 23 | 4 | EFO_0004462 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 6.83e-04 | 224 | 23 | 3 | EFO_0004530, EFO_0008317 | |
| Disease | phospholipids:total lipids ratio | 7.10e-04 | 227 | 23 | 3 | EFO_0020946 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.25e-03 | 276 | 23 | 3 | EFO_0004612, EFO_0020943 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.45e-03 | 291 | 23 | 3 | EFO_0008317, EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDMNGEHRKCNMRDA | 556 | Q9H013 | |
| MKAAHDNMDIDKVDE | 116 | Q9H444 | |
| AMELAKHDAEVQNMA | 266 | Q86YH6 | |
| NNMDENMDESDKRKC | 1066 | Q12830 | |
| MKSVHENMDLNKIDD | 116 | Q96CF2 | |
| EAHKMVREANMKQAA | 121 | Q8TBN0 | |
| DEDFQESNKMHSMNG | 611 | P00450 | |
| DAVAAMSKDKNNMQH | 246 | P31942 | |
| LMDAQKEDFNSKHMA | 1371 | P55268 | |
| KARFQHLMKSMENED | 1026 | Q9UPN3 | |
| MENKAFSMDEHNAAL | 331 | Q9NZH0 | |
| KDDQKAENDMAMKRA | 1166 | Q08AD1 | |
| CMEEAMNSSHDKKQA | 46 | Q8TBY8 | |
| EKQARDMAEAHKEAM | 106 | O00233 | |
| EAMMTKADNDNRDHK | 541 | Q96KN7 | |
| AEEMKKALEQQMESH | 696 | O60282 | |
| EDMAKADKTHYERQM | 61 | B2RPK0 | |
| AASNIVQMKDDHDKM | 21 | P49721 | |
| KMADFHKEEMDDQDK | 421 | Q9Y2W1 | |
| NAMFEHEMEESKKNR | 226 | Q6IQ16 | |
| SAMFEHEMEESKKNR | 226 | O43791 | |
| KLCKAMAHEASENDM | 696 | Q9HCF6 | |
| RQMEEETKAKNAMAH | 1321 | Q9UKX3 | |
| QKNAMEKLHSMDDAF | 946 | Q9C099 |